Vosevi (sofosbuvir/velpatasvir/voxilaprevir)
Status:
Concluded with an LOI
Manufacturer:
Gilead Sciences Canada Inc.
Indication:
Chronic Hepatitis C
Last updated February 14, 2018
Mictoryl Pediatric (propiverine hydrochloride)
Status:
Concluded with an LOI
Manufacturer:
Duchesnay Inc.
Indication:
Overactive Bladder
Last updated February 12, 2018
Mictoryl (propiverine hydrochloride)
Status:
Concluded without agreement
Manufacturer:
Duchesnay Inc.
Indication:
Overactive Bladder
Last updated February 12, 2018
Invega Trinza (paliperidone palmitate)
Status:
Concluded with an LOI
Manufacturer:
Janssen Inc.
Indication:
Schizophrenia
Last updated February 5, 2018
Status:
Concluded with an LOI
Manufacturer:
Hoffmann-La Roche Ltd.
Indication:
Follicular Lymphoma
Last updated January 16, 2018
Status:
Concluded with an LOI
Manufacturer:
Alexion Pharma GmbH
Indication:
Pediatric-onset hypophosphatasia
Last updated January 9, 2018
Narcan (naloxone hydrochloride)
Status:
Concluded with an LOI
Manufacturer:
Adapt Pharma Operations Limited
Indication:
Opioid Overdose
Last updated January 3, 2018
Status:
Concluded with an LOI
Manufacturer:
Eli Lilly Canada Inc.
Indication:
Psoriasis, moderate to severe plaque
Last updated December 29, 2017
Status:
Concluded with an LOI
Manufacturer:
Pfizer Canada ULC
Indication:
Advanced Breast Cancer
Last updated December 21, 2017
Status:
Concluded with an LOI
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Indication:
Ankylosing spondylitis
Last updated December 19, 2017